Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000053417-14-000033
Filing Date
2014-02-06
Accepted
2014-02-06 17:04:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G INITIAL ANNUAL FILING - CNAT cnat1213.txt SC 13G 7133
  Complete submission text file 0000053417-14-000033.txt   8712
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

EIN.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Subject) CIK: 0001383701 (see all company filings)

EIN.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87858 | Film No.: 14580915
SIC: 2834 Pharmaceutical Preparations